BioRestorative Therapies (OTCMKTS:BRTX) Share Price Passes Below 50-Day Moving Average of $1.52

Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXGet Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.52 and traded as low as $1.32. BioRestorative Therapies shares last traded at $1.39, with a volume of 38,263 shares changing hands.

BioRestorative Therapies Price Performance

The business’s fifty day moving average is $1.52 and its two-hundred day moving average is $1.73.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Cambridge Investment Research Advisors Inc. purchased a new position in BioRestorative Therapies during the first quarter worth $120,000. Two Sigma Investments LP purchased a new position in BioRestorative Therapies during the first quarter worth $58,000. Two Sigma Advisers LP purchased a new position in BioRestorative Therapies during the first quarter worth $99,000. State Street Corp purchased a new position in BioRestorative Therapies during the first quarter worth $70,000. Finally, Geode Capital Management LLC boosted its stake in shares of BioRestorative Therapies by 219.6% during the second quarter. Geode Capital Management LLC now owns 43,776 shares of the company’s stock valued at $193,000 after purchasing an additional 30,078 shares during the period. 6.93% of the stock is owned by hedge funds and other institutional investors.

About BioRestorative Therapies

(Get Free Report)

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.

Recommended Stories

Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.